As of Jan 20
| +0.30 / +0.43%|
The 14 analysts offering 12-month price forecasts for NuVasive Inc have a median target of 71.50, with a high estimate of 80.00 and a low estimate of 69.00. The median estimate represents a +1.72% increase from the last price of 70.29.
The current consensus among 19 polled investment analysts is to Buy stock in NuVasive Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.